Vera Therapeutics (VERA) had the highest return between January 8, 2024 and January 31, 2024 by a small-cap US stock, returning 133.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Vera Therapeutics (VERA) | 1/8/2024 - 1/31/2024 | 133.16% |
QuantaSing Group Limited American Depositary Shares (QSG) | 1/8/2024 - 1/31/2024 | 109.18% |
Clene (CLNNW) | 1/8/2024 - 1/31/2024 | 103.57% |
Edgewise Therapeutics (EWTX) | 1/8/2024 - 1/31/2024 | 78.48% |
Astria Therapeutics (ATXS) | 1/8/2024 - 1/31/2024 | 69.22% |
Praxis Precision Medicines (PRAX) | 1/8/2024 - 1/31/2024 | 67.04% |
Real Brokerage (REAX) | 1/8/2024 - 1/31/2024 | 61.02% |
Intuitive Machines (LUNR) | 1/8/2024 - 1/31/2024 | 60.85% |
Arcutis Biotherapeutics (ARQT) | 1/8/2024 - 1/31/2024 | 56.53% |
ADC Therapeutics (ADCT) | 1/8/2024 - 1/31/2024 | 53.69% |
Mereo BioPharma Group PLC ADR (MREO) | 1/8/2024 - 1/31/2024 | 51.6% |
Cullinan Oncology LLC (CGEM) | 1/8/2024 - 1/31/2024 | 50.05% |
Dianthus Therapeutics (DNTH) | 1/8/2024 - 1/31/2024 | 47.86% |
Immunome (IMNM) | 1/8/2024 - 1/31/2024 | 45.99% |
SEALSQ (LAES) | 1/8/2024 - 1/31/2024 | 45.19% |
Establishment Labs (ESTA) | 1/8/2024 - 1/31/2024 | 44.14% |
POET Technologies (POET) | 1/8/2024 - 1/31/2024 | 42.55% |
GH Research (GHRS) | 1/8/2024 - 1/31/2024 | 42.4% |
Akso Health Group ADR (AHG) | 1/8/2024 - 1/31/2024 | 40.17% |
Net Lease Office Properties (NLOP) | 1/8/2024 - 1/31/2024 | 39.92% |
Oric Pharmaceuticals (ORIC) | 1/8/2024 - 1/31/2024 | 39.82% |
Tarsus Pharmaceuticals (TARS) | 1/8/2024 - 1/31/2024 | 38.84% |
Codere Online US (CDRO) | 1/8/2024 - 1/31/2024 | 37.13% |
Innodata (INOD) | 1/8/2024 - 1/31/2024 | 36.81% |
GeneDx (WGS) | 1/8/2024 - 1/31/2024 | 36.52% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
